Biotech · Private company
Melt Pharmaceuticals
Track this companyFree. Adds Melt Pharmaceuticals to your Dealase workspace and tells you when its record changes.
Clinical trials40 recruiting or active
Pipeline programs9From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline9
- MELT-300 sublingual tabletPhase 3 · CataractClinicalTrials.gov · fetched Nov 12, 2026
- Midalozam sublingual tabletPhase 3 · CataractClinicalTrials.gov · fetched Nov 12, 2026
- Ketamine alonePhase 2 · CataractClinicalTrials.gov · fetched Nov 12, 2026
- MELT-300Phase 2 · CataractClinicalTrials.gov · fetched Nov 12, 2026
- Midazolam alonePhase 2 · CataractClinicalTrials.gov · fetched Nov 12, 2026
- Ketamine Injectable ProductPhase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- MELT-100Phase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- midazolam / ketamine sublingual tabletPhase 1 · Procedural SedationClinicalTrials.gov · fetched Nov 12, 2026
- Midazolam injectionPhase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)PHASE3 · UNKNOWN · started May 1, 2024ClinicalTrials.gov NCT06383273 · fetched Nov 12, 2026
- A Study of MELT-300 (Midazolam and Ketamine Sublingual Tablets) for Sedation and Intraoperative Ocular Analgesia in Participants Undergoing Cataract Extraction With Lens Replacement (CELR)PHASE2 · COMPLETED · started Jul 20, 2021ClinicalTrials.gov NCT05133518 · fetched Nov 12, 2026
- Relative Bioavailability Study of MELT-100, IV Midazolam, and IV KetaminePHASE1 · COMPLETED · started Dec 1, 2020ClinicalTrials.gov NCT04767035 · fetched Nov 12, 2026
- Phase 1 Bioavailability Study of MELT-100 (Midazolam and Ketamine Sublingual) and IV Midazolam or KetaminePHASE1 · COMPLETED · started Jul 20, 2020ClinicalTrials.gov NCT04485702 · fetched Nov 12, 2026